University of California, Los Angeles
BioResearch Product Faire™
A unique opportunity to advance research into the function of the human brain has been presented to three UCLA neuroscientists. Michele Basso, Dr. Peyman Golshani and Daniel Aharoni have received a $3.7 million, three-year grant from the National Institutes of Health (NIH) to develop imaging technology to record tens of thousands of neurons with the intent of learning how disease impacts the brain’s function.Read More
Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, UCLA research funding, nih research funding, university research funding, Neurological Research, Brain Disease, Healthcare Research, Mental Disorders, lab equipment suppliers, brain cancer treatment
Two UCLA research programs have earned state and federal grants totaling $18.8 million, while two departments have been given $3.35 million in private endowments, according to university news reports. The Urology Department received $9.3 million from the state of California while the Fielding School of Public Health earned a $9.5 million grant from the National Institute of Drug Abuse (NIDA).Read More
Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, cancer reserach, UCLA research funding, HIV research, Prostate cancer research, nih research funding
An estimated 15 million Americans will develop Alzheimer’s disease by 2060, according to researchers at the UCLA Fielding School of Public Health. The December 2017 study is the first of its kind to estimate the numbers of Americans with preclinical Alzheimer’s disease.
Tags: CA, UCLA School of Public Health, new research funding, Alzheimer's Research, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, Alzheimer's research market, UCLA research funding, cytomegalovirus, Geriatrics
Most people think of paralysis in terms of not being able to move or walk. But there is another side to being paralyzed , the lack of sensation. The inability to feel pain leaves the person susceptible to burns from inadvertent contact with hot surfaces. Researchers at the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have developed a new protocol which could serve as the first step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.Read More
Tags: Stem cell research, LAVS, UCLA, laboratory equipment suppliers, Lab Product Sales, research news, UC Los Angeles, BioResearch Product Faire, UCLA research funding, general lab supply, 2017 research funding, nih research funding
Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.Read More
“Despite dramatic improvements in the ability to treat and prevent HIV, the HIV rate among youth in America has doubled in the last 10 years,” Mary Jane Rotheram-Borus, director of the Global Center for Children and Families at UCLA stated in a recent article for the UCLA Newsroom. By 2020 the incidence of the disease among youths is expected to increase by 39%. Dr. Rotheram-Boras believes that if acutely infected youths were identified and treated during the period when their infectivity to others is 5-10 fold, then the medical community could reverse this trend and improve the long-term health of youths.
(Image of UCLA courtesy of Wikimedia)Read More
Tags: LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, NIH grants, UC Los Angeles, BioResearch Product Faire, UCLA research funding, Laboratory product sales, general lab supply, 2017 research funding
As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with such widespread access to cannabis, research if the drug has been limited due to the DEA classifying it as a Schedule I drug in the 1970s. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)Read More
On April 20th UCLA celebrated the grand reopening of the Jules Stein Building after a $65M renovation. This building connects to the Doris Stein Building and the Edie & Lew Wasserman Building to make up the UCLA Stein Eye Institute. Combined, the three buildings provide nearly 300,000 square feet of functional space with over 20 specially equipped laboratories to support vision science investigations.Read More